Caiqin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caiqin Wu has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Kun-Peng Li
School of Exercise and Health, Shanghai University of Sport, Shanghai, China
11 shared publications Kunpeng Li
School of Exercise and Health, Shanghai University of Sport, Shanghai, China
9 shared publicationsJieting Jiang
Oncology department, Guiqian International General Hospital, Guiyang, China
8 shared publicationsShan Wang
Department of Nursing, Tongji Hospital Affiliated to Tongji University
7 shared publicationsLibing Liang
School of Nursing, Shanghai University of Traditional Chinese Medicine
5 shared publicationsWei Zheng
Department of Breast Surgery, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China
5 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (9) , e71801
Interpreting “intermittent” psychological distress in dementia research: A classification that obscures more than it reveals
- 2 September 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (9) , e71801
Open AccessInterpreting “intermittent” psychological distress in dementia research: A classification that obscures more than it reveals
- 19 July 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-18
Exploring facilitators and barriers to health behaviors in stroke survivors: a multi-perspective qualitative study of patients, families, and healthcare professionals
Stroke is a leading global cause of mortality and long-term disability and remains a major public health challenge [1]. According to the latest Global Burden of Disease data, stroke affected 93.8 m...
- 19 July 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-18
Exploring facilitators and barriers to health behaviors in stroke survivors: a multi-perspective qualitative study of patients, families, and healthcare professionals
Stroke is a leading global cause of mortality and long-term disability and remains a major public health challenge [1]. According to the latest Global Burden of Disease data, stroke affected 93.8 m...
- Open Access
- 25 June 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Effects of Baduanjin combined with cognitive training in older adults with mild cognitive impairment of mixed etiologies: a study protocol for a randomized controlled trial
Amid the accelerating aging trend, addressing mild cognitive impairment (MCI) is critical for dementia prevention. Current evidence suggests that standalone interventions have limited efficacy, whereas combined physical‑cognitive training may yield greater benefits. However, the neurophysiological mechanisms of sequential combinations, particularly their effects on regional brain activation and functional connectivity, remain unclear. Functional near‑infrared spectroscopy (fNIRS) offers a non‑invasive tool to measure cortical oxygenation and address this gap. This 12‑week, three‑arm randomized controlled trial (RCT) will enroll 186 older adults with MCI to systematically compare sequential Baduanjin exercise (BE) followed by cognitive training (CT), BE alone, and CT alone. The primary cognitive outcome is global cognitive function, assessed with the Montreal Cognitive Assessment (MoCA). The primary neurophysiological outcome is the resting‑state change in oxyhaemoglobin (oxy‑Hb) concentration in the prefrontal (PFC), premotor (PMC), and supplementary motor (SMA) cortices, measured by fNIRS. Secondary outcomes include specific cognitive domain performance, balance, activities of daily living (ADL), resting heart rate, and heart rate variability (HRV). All measures will be assessed at baseline, immediately post‑intervention (week 12), and at a 4‑week follow‑up (week 16). This study aims to evaluate the efficacy of sequential BE followed by CT in improving cognitive function in older adults with MCI. By quantifying fNIRS‑derived PFC‑PMC‑SMA activation and connectivity, the research will elucidate how BE optimizes the neurophysiological milieu to enhance the targeted effects of CT on cognition. The findings will provide evidence for personalized multimodal interventions and advance the understanding of non‑pharmacological MCI management. Chinese Clinical Trial Registry ChiCTR2500112116. Registered 10 November 2025.
- 25 June 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Open AccessEffects of Baduanjin combined with cognitive training in older adults with mild cognitive impairment of mixed etiologies: a study protocol for a randomized controlled trial
Amid the accelerating aging trend, addressing mild cognitive impairment (MCI) is critical for dementia prevention. Current evidence suggests that standalone interventions have limited efficacy, whereas combined physical‑cognitive training may yield greater benefits. However, the neurophysiological mechanisms of sequential combinations, particularly their effects on regional brain activation and functional connectivity, remain unclear. Functional near‑infrared spectroscopy (fNIRS) offers a non‑invasive tool to measure cortical oxygenation and address this gap. This 12‑week, three‑arm randomized controlled trial (RCT) will enroll 186 older adults with MCI to systematically compare sequential Baduanjin exercise (BE) followed by cognitive training (CT), BE alone, and CT alone. The primary cognitive outcome is global cognitive function, assessed with the Montreal Cognitive Assessment (MoCA). The primary neurophysiological outcome is the resting‑state change in oxyhaemoglobin (oxy‑Hb) concentration in the prefrontal (PFC), premotor (PMC), and supplementary motor (SMA) cortices, measured by fNIRS. Secondary outcomes include specific cognitive domain performance, balance, activities of daily living (ADL), resting heart rate, and heart rate variability (HRV). All measures will be assessed at baseline, immediately post‑intervention (week 12), and at a 4‑week follow‑up (week 16). This study aims to evaluate the efficacy of sequential BE followed by CT in improving cognitive function in older adults with MCI. By quantifying fNIRS‑derived PFC‑PMC‑SMA activation and connectivity, the research will elucidate how BE optimizes the neurophysiological milieu to enhance the targeted effects of CT on cognition. The findings will provide evidence for personalized multimodal interventions and advance the understanding of non‑pharmacological MCI management. Chinese Clinical Trial Registry ChiCTR2500112116. Registered 10 November 2025.
- Open Access
- 17 June 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Exercise modalities and dosages on glycated haemoglobin and exerkines in type 2 diabetes: a systematic review with pairwise, network, and dose-response meta-analyses
Exercise is a cornerstone of type 2 diabetes mellitus (T2DM) management; however, the comparative efficacy of specific modalities, optimal dosages, and associated exerkine responses remains incompletely defined. This study aimed to synthesise evidence on the effects of different exercise types and doses on glycated haemoglobin (HbA1c) levels and to explore modality-specific patterns of exerkine regulation in adults with T2DM. A systematic review and Bayesian evidence synthesis of randomised controlled trials was conducted up to October 2025. Pairwise, network, and model-based dose-response meta-analyses were employed to evaluate the effects of eight exercise modalities on HbA1c levels. Exploratory analyses were performed to evaluate changes in circulating adiponectin, brain-derived neurotrophic factor (BDNF), interleukin-6, leptin, resistin, and tumour necrosis factor-α levels. A total of 127 trials involving 8,744 participants were included. Network meta-analysis ranked combined mind-body resistance training (tai chi + elastic bands) and high-intensity interval training (HIIT) as the most effective modalities for reducing the level of HbA1c (surface under the cumulative ranking curve: 85.9% and 78.6%, respectively). An L-shaped nonlinear dose-response relationship was observed, with the majority of the clinical benefit being achieved at 600 MET-min/week (mean difference: -0.57%; 95% credible interval: -0.72, -0.42) and a plateau beyond approximately 1,000 MET-min/week. Exploratory exerkine analyses suggested modality-specific signatures; specifically, HIIT was associated with greater increases in adiponectin levels, whereas resistance-based interventions trended towards greater reductions in interleukin-6 and tumour necrosis factor-α levels. In pairwise comparisons versus the control, no significant overall changes were detected for adiponectin, BDNF, interleukin-6, or resistin. In adults with T2DM, exercise efficacy varies by modality and follows a dose-plateau pattern. The achievement of 600 MET-min/week produces a meaningful reduction in HbA1c levels, with diminishing returns being observed beyond approximately 1,000 MET-min/week. MBRT and HIIT are the most promising modalities, although the evidence concerning MBRT remains preliminary in nature. Modality-specific exerkine patterns were observed; specifically, HIIT ranked highest for adiponectin, whereas RT ranked highest for IL-6 and TNF-α. These findings inform evidence-based, personalised exercise prescription in T2DM patients.
- 17 June 2026
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 25 (1)
Open AccessExercise modalities and dosages on glycated haemoglobin and exerkines in type 2 diabetes: a systematic review with pairwise, network, and dose-response meta-analyses
Exercise is a cornerstone of type 2 diabetes mellitus (T2DM) management; however, the comparative efficacy of specific modalities, optimal dosages, and associated exerkine responses remains incompletely defined. This study aimed to synthesise evidence on the effects of different exercise types and doses on glycated haemoglobin (HbA1c) levels and to explore modality-specific patterns of exerkine regulation in adults with T2DM. A systematic review and Bayesian evidence synthesis of randomised controlled trials was conducted up to October 2025. Pairwise, network, and model-based dose-response meta-analyses were employed to evaluate the effects of eight exercise modalities on HbA1c levels. Exploratory analyses were performed to evaluate changes in circulating adiponectin, brain-derived neurotrophic factor (BDNF), interleukin-6, leptin, resistin, and tumour necrosis factor-α levels. A total of 127 trials involving 8,744 participants were included. Network meta-analysis ranked combined mind-body resistance training (tai chi + elastic bands) and high-intensity interval training (HIIT) as the most effective modalities for reducing the level of HbA1c (surface under the cumulative ranking curve: 85.9% and 78.6%, respectively). An L-shaped nonlinear dose-response relationship was observed, with the majority of the clinical benefit being achieved at 600 MET-min/week (mean difference: -0.57%; 95% credible interval: -0.72, -0.42) and a plateau beyond approximately 1,000 MET-min/week. Exploratory exerkine analyses suggested modality-specific signatures; specifically, HIIT was associated with greater increases in adiponectin levels, whereas resistance-based interventions trended towards greater reductions in interleukin-6 and tumour necrosis factor-α levels. In pairwise comparisons versus the control, no significant overall changes were detected for adiponectin, BDNF, interleukin-6, or resistin. In adults with T2DM, exercise efficacy varies by modality and follows a dose-plateau pattern. The achievement of 600 MET-min/week produces a meaningful reduction in HbA1c levels, with diminishing returns being observed beyond approximately 1,000 MET-min/week. MBRT and HIIT are the most promising modalities, although the evidence concerning MBRT remains preliminary in nature. Modality-specific exerkine patterns were observed; specifically, HIIT ranked highest for adiponectin, whereas RT ranked highest for IL-6 and TNF-α. These findings inform evidence-based, personalised exercise prescription in T2DM patients.
- Open Access
- 2 May 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Pain-responsive to digital self-management in lumbar disc herniation: the mediating role of patient activation and the moderating effect of pain intensity
Self-management behaviors (SMB) are fundamental to outcomes in lumbar disc herniation (LDH), yet those remain frequently suboptimal. Electronic health lite
- 2 May 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessPain-responsive to digital self-management in lumbar disc herniation: the mediating role of patient activation and the moderating effect of pain intensity
Self-management behaviors (SMB) are fundamental to outcomes in lumbar disc herniation (LDH), yet those remain frequently suboptimal. Electronic health lite
- Open Access
- 20 April 2026
- Published by Elsevier in International Journal of Nursing Sciences
- Vol. 13 (3) , 348-356
Comparative efficacy of group versus individual reminiscence therapy for depression in older adults: A network meta-analysis stratified by severity
- 20 April 2026
- Published by Elsevier in International Journal of Nursing Sciences
- Vol. 13 (3) , 348-356
Open AccessComparative efficacy of group versus individual reminiscence therapy for depression in older adults: A network meta-analysis stratified by severity
- Open Access
- 28 March 2026
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 98, 103368
Response to commentary: Dissecting domain-specific cognitive gains of Baduanjin exercise in breast cancer patients receiving chemotherapy
- 28 March 2026
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 98, 103368
Open AccessResponse to commentary: Dissecting domain-specific cognitive gains of Baduanjin exercise in breast cancer patients receiving chemotherapy
- Open Access
- 3 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e87961
Combined Acupoint Massage and Abdominal Mirabilite Application for Accelerating Gastrointestinal Recovery in Pediatric Patients After Endoscopic Retrograde Cholangiopancreatography: Protocol for a Randomized Controlled Trial
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is crucial for managing pediatric hepatobiliary diseases but frequently results in postoperative gastrointestinal dysfunction such as delayed flatus and defecation, which can prolong recovery and increase the risk of complications. Nonpharmacological interventions such as acupoint massage and mirabilite application offer potential benefits, but evidence for their efficacy and synergy in children after ERCP is lacking. Objective: This study aims to evaluate the individual and combined effects of acupoint massage and abdominal mirabilite application on accelerating gastrointestinal recovery in pediatric patients following ERCP. Methods: A single-center, single-blind, randomized controlled trial will be conducted involving 72 children aged between 2 and 12 years who have undergone ERCP. Participants will be randomly allocated to 1 of the 4 groups: acupoint massage group (stimulating ST-36, ST-25, CV-12, and PC-6 for 2 minutes per point; twice daily), mirabilite group (abdominal application for 1 hour; twice daily), combination group (both interventions; at least 1 hour apart), or conventional care group. The primary outcome is the time to first postoperative flatus and defecation. The secondary outcomes include the frequency of postoperative nausea and vomiting and inflammatory markers. Data will be analyzed using intention-to-treat analysis with SPSS, using ANOVA, chi-square, and nonparametric tests as appropriate. Results: This trial is currently in progress, having received funding in January 2023 and July 2023. Participant recruitment commenced on November 1, 2024, with an anticipated completion date of October 30, 2026. As of January 2026, a total of 38 pediatric patients have been enrolled and randomized, while data collection and intervention delivery are ongoing. No interim analysis has been conducted. The final analysis will begin after recruitment and follow-up are complete, with primary results expected to be published in the second half of 2026. Conclusions: This study is the first to rigorously assess the efficacy and potential synergistic effects of acupoint massage and mirabilite application for enhancing gastrointestinal recovery after pediatric ERCP. Positive findings could establish a safe, nonpharmacological protocol to improve postoperative outcomes, reduce hospital stays, and minimize complications in this vulnerable population. Trial Registration: International Traditional Medicine Clinical Trial Registry ITMCTR2025000670; https://itmctr.ccebtcm.org.cn/mgt/project/view/3385640124071694411 International Registered Report Identifier (IRRID): DERR1-10.2196/87961
- 3 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e87961
Open AccessCombined Acupoint Massage and Abdominal Mirabilite Application for Accelerating Gastrointestinal Recovery in Pediatric Patients After Endoscopic Retrograde Cholangiopancreatography: Protocol for a Randomized Controlled Trial
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is crucial for managing pediatric hepatobiliary diseases but frequently results in postoperative gastrointestinal dysfunction such as delayed flatus and defecation, which can prolong recovery and increase the risk of complications. Nonpharmacological interventions such as acupoint massage and mirabilite application offer potential benefits, but evidence for their efficacy and synergy in children after ERCP is lacking. Objective: This study aims to evaluate the individual and combined effects of acupoint massage and abdominal mirabilite application on accelerating gastrointestinal recovery in pediatric patients following ERCP. Methods: A single-center, single-blind, randomized controlled trial will be conducted involving 72 children aged between 2 and 12 years who have undergone ERCP. Participants will be randomly allocated to 1 of the 4 groups: acupoint massage group (stimulating ST-36, ST-25, CV-12, and PC-6 for 2 minutes per point; twice daily), mirabilite group (abdominal application for 1 hour; twice daily), combination group (both interventions; at least 1 hour apart), or conventional care group. The primary outcome is the time to first postoperative flatus and defecation. The secondary outcomes include the frequency of postoperative nausea and vomiting and inflammatory markers. Data will be analyzed using intention-to-treat analysis with SPSS, using ANOVA, chi-square, and nonparametric tests as appropriate. Results: This trial is currently in progress, having received funding in January 2023 and July 2023. Participant recruitment commenced on November 1, 2024, with an anticipated completion date of October 30, 2026. As of January 2026, a total of 38 pediatric patients have been enrolled and randomized, while data collection and intervention delivery are ongoing. No interim analysis has been conducted. The final analysis will begin after recruitment and follow-up are complete, with primary results expected to be published in the second half of 2026. Conclusions: This study is the first to rigorously assess the efficacy and potential synergistic effects of acupoint massage and mirabilite application for enhancing gastrointestinal recovery after pediatric ERCP. Positive findings could establish a safe, nonpharmacological protocol to improve postoperative outcomes, reduce hospital stays, and minimize complications in this vulnerable population. Trial Registration: International Traditional Medicine Clinical Trial Registry ITMCTR2025000670; https://itmctr.ccebtcm.org.cn/mgt/project/view/3385640124071694411 International Registered Report Identifier (IRRID): DERR1-10.2196/87961
- Open Access
- 9 January 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
The efficacy of reminiscence therapy on the cognition of older patients with cognitive impairment or dementia: a meta-analysis based on regulatory factors
Background With global aging, dementia prevalence is rising, imposing significant burdens. Reminiscence therapy (RT) shows promise for improving cognition in older adults with cognitive impairment or dementia, but evidence remains inconsistent, potentially moderated by factors like age, intervention frequency, and setting. Aims This systematic review and network meta-analysis aimed to evaluate RT’s efficacy on cognitive function in older patients with cognitive impairment or dementia and identify moderating factors through subgroup analyses. Methods A comprehensive search was conducted across 11 English and Chinese databases from inception until May 1, 2025, to identify eligible randomized controlled trials (RCTs) evaluating RT versus standard care in older adults with cognitive impairment or dementia, utilizing the cognitive outcome. Two independent reviewers screened the studies, extracted data, and assessed risk of bias and evidence quality. Using RevMan 5.4 for meta-analysis and subgroup analysis. Results Twenty-four RCTs involving 1,963 patients were included. RT significantly improved cognitive function, with benefits sustained at follow-up. RT also improved memory, reduced depression, and enhanced quality of life, but not executive function. Subgroup analyses revealed significantly greater cognitive improvement in patients aged 60–70 years, with intervention frequencies of 12–16 sessions, and in nursing home settings. Conclusion RT is an effective intervention for improving cognition, memory, depression, and quality of life in older adults with cognitive impairment or dementia. Patient age, intervention frequency, and setting are potential moderators of its cognitive efficacy, providing actionable insights for optimizing clinical RT protocols.
- 9 January 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
Open AccessThe efficacy of reminiscence therapy on the cognition of older patients with cognitive impairment or dementia: a meta-analysis based on regulatory factors
Background With global aging, dementia prevalence is rising, imposing significant burdens. Reminiscence therapy (RT) shows promise for improving cognition in older adults with cognitive impairment or dementia, but evidence remains inconsistent, potentially moderated by factors like age, intervention frequency, and setting. Aims This systematic review and network meta-analysis aimed to evaluate RT’s efficacy on cognitive function in older patients with cognitive impairment or dementia and identify moderating factors through subgroup analyses. Methods A comprehensive search was conducted across 11 English and Chinese databases from inception until May 1, 2025, to identify eligible randomized controlled trials (RCTs) evaluating RT versus standard care in older adults with cognitive impairment or dementia, utilizing the cognitive outcome. Two independent reviewers screened the studies, extracted data, and assessed risk of bias and evidence quality. Using RevMan 5.4 for meta-analysis and subgroup analysis. Results Twenty-four RCTs involving 1,963 patients were included. RT significantly improved cognitive function, with benefits sustained at follow-up. RT also improved memory, reduced depression, and enhanced quality of life, but not executive function. Subgroup analyses revealed significantly greater cognitive improvement in patients aged 60–70 years, with intervention frequencies of 12–16 sessions, and in nursing home settings. Conclusion RT is an effective intervention for improving cognition, memory, depression, and quality of life in older adults with cognitive impairment or dementia. Patient age, intervention frequency, and setting are potential moderators of its cognitive efficacy, providing actionable insights for optimizing clinical RT protocols.